UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 14

of 'Treatment of relapsed or refractory acute lymphoblastic leukemia in adults'

14
TI
BLAST: A confirmatory, single-arm, phase 2 study of blinatumomab, a bispecific T-cell engager (BiTE) antibody construct, in patients with minimal residual disease B-precursor acute lymphoblastic leukemia (abstract 0379)
AU
Goekbuget N,Bargou RC,Richle A,Graux C,Havelange V,Bruggemann M
SO
Blood. 2014;
 
AD